Scopus Biopharma Completes Recapitalization Designed To Enhance Shareholder Value
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 3rd Annual STING & TLR-Targeting Therapies Summit
Scopus BioPharma to Present at the LD Micro Main Event
Scopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conference
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
